A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3

References

• Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, et al. Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A 2010; 107:18545 - 50; http://dx.doi.org/10.1073/pnas.1010978107; PMID: 20876136
   PubMed Web of Science ®Google Scholar
• Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011; 39:Database issue D945 - 50; http://dx.doi.org/10.1093/nar/gkq929; PMID: 20952405
   PubMed Web of Science ®Google Scholar
• Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004; 432:307 - 15; http://dx.doi.org/10.1038/nature03098; PMID: 15549092
   PubMed Web of Science ®Google Scholar
• Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev 2010; 24:2463 - 79; http://dx.doi.org/10.1101/gad.1971610; PMID: 21078816
   PubMed Web of Science ®Google Scholar
• Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010; 10:51 - 7; http://dx.doi.org/10.1038/nrc2772; PMID: 20029423
   PubMed Web of Science ®Google Scholar
• Ohtani N, Mann DJ, Hara E. Cellular senescence: its role in tumor suppression and aging. Cancer Sci 2009; 100:792 - 7; http://dx.doi.org/10.1111/j.1349-7006.2009.01123.x; PMID: 19302284
   PubMed Web of Science ®Google Scholar
• Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92:9363 - 7; http://dx.doi.org/10.1073/pnas.92.20.9363; PMID: 7568133
   PubMed Web of Science ®Google Scholar
• Verschuren EW, Ban KH, Masek MA, Lehman NL, Jackson PK. Loss of Emi1-dependent APC/C inhibition deregulates E2F target expression and elicits DNA damage-induced senescence. Mol Cell Biol 2007; 27:7955 - 65; http://dx.doi.org/10.1128/MCB.00908-07; PMID: 17875940
   PubMed Web of Science ®Google Scholar
• Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444:633 - 7; http://dx.doi.org/10.1038/nature05268; PMID: 17136093
   PubMed Web of Science ®Google Scholar
• Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444:638 - 42; http://dx.doi.org/10.1038/nature05327; PMID: 17136094
   PubMed Web of Science ®Google Scholar
• Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004; 428:431 - 7; http://dx.doi.org/10.1038/nature02371; PMID: 15042092
   PubMed Web of Science ®Google Scholar
• Mullenders J, Fabius AW, Madiredjo M, Bernards R, Beijersbergen RL. A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway. PLoS One 2009; 4:e4798; http://dx.doi.org/10.1371/journal.pone.0004798; PMID: 19277210
   PubMed Web of Science ®Google Scholar
• Rovillain E, Mansfield L, Lord CJ, Ashworth A, Jat PS. An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescence. BMC Genomics 2011; 12:355; http://dx.doi.org/10.1186/1471-2164-12-355; PMID: 21740549
   PubMed Web of Science ®Google Scholar
• Campisi J. Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev 2011; 21:107 - 12; http://dx.doi.org/10.1016/j.gde.2010.10.005; PMID: 21093253
   PubMed Web of Science ®Google Scholar
• Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455:1069 - 75; http://dx.doi.org/10.1038/nature07423; PMID: 18948947
   PubMed Web of Science ®Google Scholar
• Wood LD, Calhoun ES, Silliman N, Ptak J, Szabo S, Powell SM, et al. Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. Hum Mutat 2006; 27:1060 - 1; http://dx.doi.org/10.1002/humu.9452; PMID: 16941478
   PubMedGoogle Scholar
• Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446:153 - 8; http://dx.doi.org/10.1038/nature05610; PMID: 17344846
   PubMed Web of Science ®Google Scholar
• Bardelli A, Parsons DW, Silliman N, Ptak J, Szabo S, Saha S, et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 2003; 300:949; http://dx.doi.org/10.1126/science.1082596; PMID: 12738854
   PubMed Web of Science ®Google Scholar
• Easty DJ, Bennett DC. Protein tyrosine kinases in malignant melanoma. Melanoma Res 2000; 10:401 - 11; http://dx.doi.org/10.1097/00008390-200010000-00001; PMID: 11095400
   PubMed Web of Science ®Google Scholar
• Wykosky J, Debinski W. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting. Mol Cancer Res 2008; 6:1795 - 806; http://dx.doi.org/10.1158/1541-7786.MCR-08-0244; PMID: 19074825
   PubMed Web of Science ®Google Scholar
• Lackmann M, Boyd AW. Eph, a protein family coming of age: more confusion, insight, or complexity?. Sci Signal 2008; 1:re2; http://dx.doi.org/10.1126/stke.115re2; PMID: 18413883
   PubMed Web of Science ®Google Scholar
• Oricchio E, Nanjangud G, Wolfe AL, Schatz JH, Mavrakis KJ, Jiang M, et al. The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell 2011; 147:554 - 64; http://dx.doi.org/10.1016/j.cell.2011.09.035; PMID: 22036564
   PubMed Web of Science ®Google Scholar
• Lisabeth EM, Fernandez C, Pasquale EB. Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms. Biochemistry 2012; 51:1464 - 75; http://dx.doi.org/10.1021/bi2014079; PMID: 22242939
   PubMed Web of Science ®Google Scholar
• Zhuang G, Song W, Amato K, Hwang Y, Lee K, Boothby M, et al. Effects of cancer-associated EPHA3 mutations on lung cancer. J Natl Cancer Inst 2012; 104:1182 - 97; http://dx.doi.org/10.1093/jnci/djs297; PMID: 22829656
   PubMed Web of Science ®Google Scholar
• Nachury MV, Loktev AV, Zhang Q, Westlake CJ, Peränen J, Merdes A, et al. A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell 2007; 129:1201 - 13; http://dx.doi.org/10.1016/j.cell.2007.03.053; PMID: 17574030
   PubMed Web of Science ®Google Scholar
• Loewer A, Batchelor E, Gaglia G, Lahav G. Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells. Cell 2010; 142:89 - 100; http://dx.doi.org/10.1016/j.cell.2010.05.031; PMID: 20598361
   PubMed Web of Science ®Google Scholar
• Lu LY, Wood JL, Ye L, Minter-Dykhouse K, Saunders TL, Yu X, et al. Aurora A is essential for early embryonic development and tumor suppression. J Biol Chem 2008; 283:31785 - 90; http://dx.doi.org/10.1074/jbc.M805880200; PMID: 18801727
   PubMed Web of Science ®Google Scholar
• Elyada E, Pribluda A, Goldstein RE, Morgenstern Y, Brachya G, Cojocaru G, et al. CKIα ablation highlights a critical role for p53 in invasiveness control. Nature 2011; 470:409 - 13; http://dx.doi.org/10.1038/nature09673; PMID: 21331045
   PubMed Web of Science ®Google Scholar
• St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, Brownstein DG, et al. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet 1999; 21:182 - 6; http://dx.doi.org/10.1038/5965; PMID: 9988269
   PubMed Web of Science ®Google Scholar
• Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010; 19:491 - 505; http://dx.doi.org/10.1016/j.devcel.2010.09.011; PMID: 20951342
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474:609 - 15; http://dx.doi.org/10.1038/nature10166; PMID: 21720365
   PubMed Web of Science ®Google Scholar
• Janes PW, Adikari S, Lackmann M. Eph/ephrin signalling and function in oncogenesis: lessons from embryonic development. Curr Cancer Drug Targets 2008; 8:473 - 9; http://dx.doi.org/10.2174/156800908785699315; PMID: 18781894
   PubMed Web of Science ®Google Scholar
• Binns KL, Taylor PP, Sicheri F, Pawson T, Holland SJ. Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors. Mol Cell Biol 2000; 20:4791 - 805; http://dx.doi.org/10.1128/MCB.20.13.4791-4805.2000; PMID: 10848605
   PubMed Web of Science ®Google Scholar
• Davis TL, Walker JR, Loppnau P, Butler-Cole C, Allali-Hassani A, Dhe-Paganon S. Autoregulation by the juxtamembrane region of the human ephrin receptor tyrosine kinase A3 (EphA3). Structure 2008; 16:873 - 84; http://dx.doi.org/10.1016/j.str.2008.03.008; PMID: 18547520
   PubMed Web of Science ®Google Scholar
• Nievergall E, Janes PW, Stegmayer C, Vail ME, Haj FG, Teng SW, et al. PTP1B regulates Eph receptor function and trafficking. J Cell Biol 2010; 191:1189 - 203; http://dx.doi.org/10.1083/jcb.201005035; PMID: 21135139
   PubMed Web of Science ®Google Scholar
• Chen Z, Cheng K, Walton Z, Wang Y, Ebi H, Shimamura T, et al. A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature 2012; 483:613 - 7; http://dx.doi.org/10.1038/nature10937; PMID: 22425996
   PubMed Web of Science ®Google Scholar
• Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009; 9:153 - 66; http://dx.doi.org/10.1038/nrc2602; PMID: 19238148
   PubMed Web of Science ®Google Scholar
• Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE, et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev 2011; 25:2125 - 36; http://dx.doi.org/10.1101/gad.17276711; PMID: 21979375
   PubMed Web of Science ®Google Scholar
• Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002; 109:335 - 46; http://dx.doi.org/10.1016/S0092-8674(02)00734-1; PMID: 12015983
   PubMed Web of Science ®Google Scholar
• Salminen A, Kauppinen A, Kaarniranta K. Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP). Cell Signal 2012; 24:835 - 45; http://dx.doi.org/10.1016/j.cellsig.2011.12.006; PMID: 22182507
   PubMed Web of Science ®Google Scholar
• Guerra C, Collado M, Navas C, Schuhmacher AJ, Hernández-Porras I, Cañamero M, et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011; 19:728 - 39; http://dx.doi.org/10.1016/j.ccr.2011.05.011; PMID: 21665147
   PubMed Web of Science ®Google Scholar
• Huck JJ, Zhang M, McDonald A, Bowman D, Hoar KM, Stringer B, et al. MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo. Mol Cancer Res 2010; 8:373 - 84; http://dx.doi.org/10.1158/1541-7786.MCR-09-0300; PMID: 20197380
   PubMed Web of Science ®Google Scholar
• Zhang W, Peng G, Lin SY, Zhang P. DNA damage response is suppressed by the high cyclin-dependent kinase 1 activity in mitotic mammalian cells. J Biol Chem 2011; 286:35899 - 905; http://dx.doi.org/10.1074/jbc.M111.267690; PMID: 21878640
   PubMed Web of Science ®Google Scholar
• Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, et al. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 2006; 8:1291 - 7; http://dx.doi.org/10.1038/ncb1491; PMID: 17028578
   PubMed Web of Science ®Google Scholar
• Jia M, Souchelnytskyi N, Hellman U, O”Hare M, Jat PS, Souchelnytskyi S. Proteome profiling of immortalization-to-senescence transition of human breast epithelial cells identified MAP2K3 as a senescence-promoting protein which is downregulated in human breast cancer. Proteomics Clin Appl 2010; 4:816 - 28; http://dx.doi.org/10.1002/prca.201000006; PMID: 21137025
   PubMed Web of Science ®Google Scholar
• Brumbaugh KM, Otterness DM, Geisen C, Oliveira V, Brognard J, Li X, et al. The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells. Mol Cell 2004; 14:585 - 98; http://dx.doi.org/10.1016/j.molcel.2004.05.005; PMID: 15175154
   PubMed Web of Science ®Google Scholar
• Nievergall E, Lackmann M, Janes PW. Eph-dependent cell-cell adhesion and segregation in development and cancer. Cell Mol Life Sci 2012; 69:1813 - 42; http://dx.doi.org/10.1007/s00018-011-0900-6; PMID: 22204021
   PubMed Web of Science ®Google Scholar
• Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 2010; 10:165 - 80; http://dx.doi.org/10.1038/nrc2806; PMID: 20179713
   PubMed Web of Science ®Google Scholar
• Vecchi M, Confalonieri S, Nuciforo P, Viganò MA, Capra M, Bianchi M, et al. Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene 2008; 27:2148 - 58; http://dx.doi.org/10.1038/sj.onc.1210858; PMID: 17952122
   PubMed Web of Science ®Google Scholar
• Xi HQ, Wu XS, Wei B, Chen L. Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival. J Gastroenterol 2012; 47:785 - 94; http://dx.doi.org/10.1007/s00535-012-0549-4; PMID: 22350700
   PubMed Web of Science ®Google Scholar
• Guan M, Liu L, Zhao X, Wu Q, Yu B, Shao Y, et al. Copy number variations of EphA3 are associated with multiple types of hematologic malignancies. Clin Lymphoma Myeloma Leuk 2011; 11:50 - 3; http://dx.doi.org/10.3816/CLML.2011.n.006; PMID: 21454190
   PubMed Web of Science ®Google Scholar
• Miao H, Nickel CH, Cantley LG, Bruggeman LA, Bennardo LN, Wang B. EphA kinase activation regulates HGF-induced epithelial branching morphogenesis. J Cell Biol 2003; 162:1281 - 92; http://dx.doi.org/10.1083/jcb.200304018; PMID: 14517207
   PubMed Web of Science ®Google Scholar
• Vaidya A, Pniak A, Lemke G, Brown A. EphA3 null mutants do not demonstrate motor axon guidance defects. Mol Cell Biol 2003; 23:8092 - 8; http://dx.doi.org/10.1128/MCB.23.22.8092-8098.2003; PMID: 14585969
   PubMed Web of Science ®Google Scholar
• Stephen LJ, Fawkes AL, Verhoeve A, Lemke G, Brown A. A critical role for the EphA3 receptor tyrosine kinase in heart development. Dev Biol 2007; 302:66 - 79; http://dx.doi.org/10.1016/j.ydbio.2006.08.058; PMID: 17046737
   PubMed Web of Science ®Google Scholar
• Gray DC, Hoeflich KP, Peng L, Gu Z, Gogineni A, Murray LJ, et al. pHUSH: a single vector system for conditional gene expression. BMC Biotechnol 2007; 7:61; http://dx.doi.org/10.1186/1472-6750-7-61; PMID: 17897455
   PubMed Web of Science ®Google Scholar
• Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296:550 - 3; http://dx.doi.org/10.1126/science.1068999; PMID: 11910072
   PubMed Web of Science ®Google Scholar
• Haverty PM. genoset: Provides classes similar to ExpressionSet for copy number analysis. R package version 1.2.0. http://www.bioconductor.org. 2011.
   Google Scholar